Facundo Davaro
Saint Louis University
55 Papers
44 Citations
Facundo Davaro is an academic researcher from Saint Louis University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 4, co-authored 19 publications.
Chat about Author
Papers
Invasive non-urachal adenocarcinoma of the bladder: analysis of the National Cancer Database
TL;DR: Reviewing the United States National Cancer Database from 2004 to 2015 and analyzing survival outcomes of invasive non-urachal adenocarcinoma based on treatment modality found survival benefits in patients without metastatic disease are seen only in those patients undergoing definitive surgery.
24
Trends in utilization of neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
Coleman McFerrin,Facundo Davaro,Allison May,Syed Johar Raza,Sameer Siddiqui,Zachary Hamilton +5 more
TL;DR: The increasing use of perioperative chemotherapy noted in prior studies has continued through 2015, and neoadjuvant chemotherapy appears to drive this increase while adjuvant chemotherapy utilization remains unchanged.
Sequential Intravesical Gemcitabine and Docetaxel is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer.
Wei Shen Tan,Ian McElree,Facundo Davaro,Ryan L. Steinberg,Kelly K. Bree,Neema Navai,Colin P.N. Dinney,Michael A. O’Donnell,RogerW . Li,Ashish M. Kamat,Vignesh T. Packiam +10 more
TL;DR: The results show that a chemotherapy combination of docetaxel and gemcitabine is as effective as the BCG (bacillus Calmette-Guérin) treatment traditionally used for this type of bladder cancer.
20
A Lack of Palliative Therapy Use in Patients With Advanced Penile Cancer.
TL;DR: Its use is more common in younger patients, those with co-morbidities and/or those of black race in the metastatic group, and Locally advanced patients with low income or comorbidities were also more likely to opt for palliative therapy.
15
Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
Heather L. Huelster,Billie Gould,Elizabeth A. Schiftan,Lucia Camperlengo,Facundo Davaro,Kyle M. Rose,Alex Soupir,Shidong Jia,Tiantian Zheng,Wade J. Sexton,Julio M. Pow-Sang,Philippe E. Spiess,G. Daniel Grass,Liang Wang,Xuefeng Wang,Aram Vosoughi,Andrea Necchi,Joshua J Meeks,Bishoy Faltas,Pan Du,RogerW . Li +20 more
TL;DR: The detection of plasma ctDNA prior to extirpative surgery was highly predictive of MI/NOC UTUC and strongly prognostic of PFS and CSS and demonstrates promise as a biomarker for selecting patients to undergo neoadjuvant chemotherapy prior to nephroureterectomy.
13